Announcements Trials

Browse Landscape

Phase

Phase NA 11 Phase 4 3 Phase 2 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Myeloid, Accelerated Phase 2 Blast Crisis 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Diseases 1 Graft vs Host Disease 1 Gastrointestinal Stromal Tumors 1 Breast Neoplasms 1

Interventions

pembrolizumab 74 Nivolumab 53 Ipilimumab 42 Cyclophosphamide 31 Interleukin-2 24 aldesleukin 23 Temozolomide 17 fludarabine 15 Biopsy 11 trametinib 10 dabrafenib 10 fludarabine phosphate 9 spartalizumab 8 Paclitaxel 8 Dacarbazine 8 sargramostim 7 cemiplimab 7 binimetinib 7 Cisplatin 7 Bevacizumab 7 poly ICLC 6 lenvatinib 6 epacadostat 6 Radiotherapy 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 montanide ISA 51 5 encorafenib 5 atezolizumab 5 Vemurafenib 5 Specimen Handling 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Melanoma × Blood Specimen Collection × Clear all

NCT07422805 2026-05-27

ctDNA

Institute of Oncology Ljubljana

Phase 1/2 Active not recruiting

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡